What’s next for boards in the UK pharma and life sciences industry? Navigating the challenges of innovation, productivity and ESG in a post Covid world‪.‬ Board Agenda: Podcast

What’s next for boards in the UK pharma and life sciences industry? Navigating the challenges of innovation, productivity and ESG in a post Covid world. The life science industry is in a dynamic phase of transformation which has been rapidly accelerated by the pandemic, with more workforce agility, shortening development and review times, increased speed to market, and greater efficiencies. In response to the pandemic, life sciences companies mobilized impressively to meet the needs of ...